Chapter 34: Women's Health Drugs

Beginning with female reproductive physiology, the material establishes how follicle-stimulating hormone and luteinizing hormone regulate the ovarian cycle and how estradiol and progesterone coordinate ovulation, endometrial proliferation, and pregnancy maintenance. Estrogen formulations including conjugated estrogens, estradiol, and ethinyl estradiol serve multiple clinical purposes: alleviating menopausal vasomotor symptoms, preventing bone loss, providing contraceptive effects, and treating hormone-responsive malignancies. However, estrogen therapy carries significant risks of thromboembolism, endometrial hyperplasia, breast cancer, and cardiovascular complications, with interactions occurring through anticoagulants, enzyme-inducing antibiotics, and herbal products. Progestin medications such as medroxyprogesterone, norethindrone, levonorgestrel, and megestrol function in contraception, correction of abnormal uterine bleeding, endometriosis management, and endometrial protection during estrogen replacement. Contraceptive formulations vary in estrogen-progestin dosing patterns and delivery systems, including monophasic and multiphasic oral tablets, extended-cycle regimens, injectable suspensions, transdermal patches, and vaginal ring devices, all working through overlapping mechanisms of ovulation suppression and cervical mucus alterations. Osteoporosis pharmacotherapy encompasses bisphosphonates that inhibit bone resorption, selective estrogen receptor modulators that provide tissue-specific estrogenic effects, anabolic agents like teriparatide that stimulate osteoblasts, and newer monoclonal antibody therapies targeting osteoclast activation. Fertility interventions employ clomiphene citrate and gonadotropins to induce ovulation in anovulatory conditions. Uterine stimulants including oxytocin, prostaglandin analogs, and ergot alkaloids facilitate labor progression and manage postpartum hemorrhage, while tocolytic agents such as calcium channel blockers, nonsteroidal anti-inflammatory drugs, and magnesium sulfate suppress premature contractions. Nursing practice requires comprehensive assessment of cardiovascular and thromboembolic risk factors, meticulous patient education regarding medication adherence and side effect recognition, careful monitoring during pregnancy and postpartum periods, and awareness of black box warnings and contraindications specific to each drug class.